Skip to content
Disclosery

VHCP Management, LLC

Follow

13F filer, CIK 1479355, NEW YORK, NY

VHCP Management, LLC reported $101,687,000 across 24 holdings for the quarter ended 2016-09-30, in a 13F-HR filed 2016-11-14. Its ten largest share positions make up 84.52% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-16-022473

Period
2016-09-30
Reported value
$102M
Holdings
24
Top 10 weight
84.52%
New
3
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
COLUCID PHARMACEUTICALS INCnew+68,190$2.6M
ACHILLION PHARMACEUTICALS INnew+180,000$1.46M
AUDENTES THERAPEUTICS INC.new+15,000$267K
OCERA THERAPEUTICS INC COMadded+60,000$158K
Alcobra Ltdadded+35,597$88K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CHRSreduced-305,505-$8.18M
Cynapsus Therapeutics Incexited-108,575-$1.81M
GLOBAL BLOOD THERAPEUTICS U…exited-72,990-$1.21M
RGNXreduced-28,411-$397K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2016

Share positions as resolved from 13F-HR 0000950123-16-022473, largest first. % of portfolio is the value over $101,687,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
DBV TechnologiesDBV TechnologiesQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: 693,810 shares; 2015Q2: 693,810 shares; 2015Q3: 693,810 shares; 2015Q4: 463,643 shares; 2016Q1: 456,893 shares; 2016Q2: 456,893 shares; 2016Q3: 456,893 shares 456,893$32.5M31.95%0
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: 1,095,734 shares; 2015Q2: 1,095,734 shares; 2015Q3: 1,095,734 shares; 2015Q4: 1,095,734 shares; 2016Q1: 1,095,734 shares; 2016Q2: 1,095,734 shares; 2016Q3: 1,095,734 shares 1,095,734$18.9M18.57%0Timeline
CHRSCOHERUS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: 870,269 shares; 2015Q2: 870,269 shares; 2015Q3: 870,269 shares; 2015Q4: 611,010 shares; 2016Q1: 611,010 shares; 2016Q2: 611,010 shares; 2016Q3: 305,505 shares 305,505$8.18M8.05%-305,505Timeline
FLAMEL TECHNOLOGIES-SP ADRFLAMEL TECHNOLOGIES-SP ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: 500,000 shares; 2015Q2: 500,000 shares; 2015Q3: 500,000 shares; 2015Q4: 500,000 shares; 2016Q1: 500,000 shares; 2016Q2: 500,000 shares; 2016Q3: 500,000 shares 500,000$6.2M6.1%0
Adverum Biotechnologies, In…Adverum Biotechnologies, Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: not reported; 2016Q2: 1,102,735 shares; 2016Q3: 1,102,735 shares 1,102,735$4.53M4.46%0
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: 1,744,356 shares; 2015Q2: 373,686 shares; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: 562,943 shares; 2016Q2: 1,005,104 shares; 2016Q3: 1,005,104 shares 1,005,104$4.43M4.36%0Timeline
LIPOCINE INC NEWLIPOCINE INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: 669,921 shares; 2015Q2: 1,269,921 shares; 2015Q3: 1,269,921 shares; 2015Q4: 849,921 shares; 2016Q1: 849,921 shares; 2016Q2: 849,921 shares; 2016Q3: 849,921 shares 849,921$3.79M3.73%0
COLUCID PHARMACEUTICALS INCCOLUCID PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: not reported; 2016Q2: not reported; 2016Q3: 68,190 shares 68,190$2.6M2.56%new
AXOVANT SCIENCES LTDAXOVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: 184,110 shares; 2016Q2: 184,110 shares; 2016Q3: 184,110 shares 184,110$2.58M2.54%0
OCERA THERAPEUTICS INC COMOCERA THERAPEUTICS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: 703,730 shares; 2015Q2: 703,730 shares; 2015Q3: 703,730 shares; 2015Q4: 703,730 shares; 2016Q1: 796,550 shares; 2016Q2: 796,550 shares; 2016Q3: 856,550 shares 856,550$2.26M2.22%+60,000
ZAFGEN INCZAFGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: 541,480 shares; 2015Q2: 541,480 shares; 2015Q3: 541,480 shares; 2015Q4: 541,480 shares; 2016Q1: 602,114 shares; 2016Q2: 602,114 shares; 2016Q3: 602,114 shares 602,114$1.99M1.96%0
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: 811,152 shares; 2015Q2: 811,152 shares; 2015Q3: 811,152 shares; 2015Q4: 90,000 shares; 2016Q1: 90,000 shares; 2016Q2: 90,000 shares; 2016Q3: 90,000 shares 90,000$1.81M1.78%0Timeline
Alcobra LtdAlcobra LtdQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: 1,500,000 shares; 2015Q2: 1,500,000 shares; 2015Q3: 1,500,000 shares; 2015Q4: 484,500 shares; 2016Q1: 484,500 shares; 2016Q2: 623,313 shares; 2016Q3: 658,910 shares 658,910$1.63M1.6%+35,597
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: 51,000 shares; 2016Q2: 51,000 shares; 2016Q3: 51,000 shares 51,000$1.57M1.54%0Timeline
STEMLINE THERAPEUTICS INCSTEMLINE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: 451,400 shares; 2015Q2: 451,400 shares; 2015Q3: 451,400 shares; 2015Q4: 135,420 shares; 2016Q1: 135,420 shares; 2016Q2: 135,420 shares; 2016Q3: 135,420 shares 135,420$1.47M1.44%0
ACHILLION PHARMACEUTICALS INACHILLION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: not reported; 2016Q2: not reported; 2016Q3: 180,000 shares 180,000$1.46M1.43%new
EDGE THERAPEUTICS INCEDGE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: 135,000 shares; 2016Q1: 135,000 shares; 2016Q2: 135,000 shares; 2016Q3: 135,000 shares 135,000$1.41M1.38%0
AKARI THERAPEUTICS PLCAKARI THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 527,842 shares; 2015Q4: 158,352 shares; 2016Q1: 158,352 shares; 2016Q2: 158,352 shares; 2016Q3: 158,352 shares 158,352$1.35M1.33%0
ARCA biopharma IncARCA biopharma IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: 10,789,324 shares; 2015Q3: 1,541,331 shares; 2015Q4: 462,399 shares; 2016Q1: 462,399 shares; 2016Q2: 462,399 shares; 2016Q3: 462,399 shares 462,399$1.31M1.29%0
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: 75,000 shares; 2016Q1: 64,200 shares; 2016Q2: 64,200 shares; 2016Q3: 64,200 shares 64,200$1.01M0.99%0Timeline
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 1,083,454 shares; 2015Q4: 52,500 shares; 2016Q1: 52,500 shares; 2016Q2: 52,500 shares; 2016Q3: 24,089 shares 24,089$337K0.33%-28,411Timeline
AUDENTES THERAPEUTICS INC.AUDENTES THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: not reported; 2016Q2: not reported; 2016Q3: 15,000 shares 15,000$267K0.26%new
Sierra Oncology, Inc.Sierra Oncology, Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 250,000 shares; 2015Q4: 75,000 shares; 2016Q1: 56,056 shares; 2016Q2: 56,056 shares; 2016Q3: 56,056 shares 56,056$102K0.1%0
AEGLEA BIOTHERAPEUTICS INCAEGLEA BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: not reported; 2016Q2: 6,000 shares; 2016Q3: 6,000 shares 6,000$38K0.04%0

Sold out in Q3 2016

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
Cynapsus Therapeutics IncCynapsus Therapeutics Inc108,575$1.81Mshares
GLOBAL BLOOD THERAPEUTICS U…GLOBAL BLOOD THERAPEUTICS USD72,990$1.21Mshares

How Q3 2016 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-16-022473 base2016-11-14acceptance time not in the bulk data set